Targovax ASA (0RIS) Financial Statements
Targovax ASA Financial Overview
Targovax ASA's market cap is currently $2.97B. The company's EPS TTM is $-0.39; its P/E ratio is -26.40; Targovax ASA has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 123.00K | $ 10.00M | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 123.00K | $ 10.00M | $ 0.00 |
| Operating Income | $ -41.05M | $ -42.49M | $ -99.97M | $ -493.59M | $ -95.60M |
| EBITDA | $ -45.71M | $ 57.56M | $ -107.61M | $ -97.66M | $ -94.68M |
| Net Income | $ -45.91M | $ 57.52M | $ -112.94M | $ -432.90M | $ -97.97M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.04M | $ 18.21M | $ 21.90M | $ 62.97M | $ 181.68M |
| Total Assets | $ 10.76M | $ 21.83M | $ 25.71M | $ 100.41M | $ 565.27M |
| Total Debt | $ 8.37M | $ 17.36M | $ 110.43M | $ 63.42M | $ 59.79M |
| Net Debt | $ 2.32M | $ -857.00K | $ 88.53M | $ 452.00K | $ -121.89M |
| Total Liabilities | $ 23.25M | $ 34.34M | $ 124.25M | $ 97.85M | $ 147.54M |
| Stockholders' Equity | $ -12.49M | $ -12.51M | $ -98.54M | $ 2.57M | $ 417.73M |
| Cash Flow | |||||
| Free Cash Flow | $ -45.82M | $ -40.72M | $ -89.39M | $ -113.80M | $ -85.40M |
| Operating Cash Flow | $ -45.82M | $ -40.53M | $ -89.20M | $ -108.84M | $ -85.40M |
| Investing Cash Flow | $ 0.00 | $ -189.00K | $ 2.95M | $ -4.96M | $ 1.00K |
| Financing Cash Flow | $ 33.60M | $ 36.63M | $ 41.93M | $ -4.33M | $ 145.61M |
Currency in NOK